Sort   by:  
 Page size 
ProteomicsCD32A Immunoprecipitation in K562 Cell Membrane and Cytoplasm Fractions
Here we interrogate CD32A protein interactions in the cytoplasm and membrane fractions isolated from the human AML cell lines K562 wild-type and knockout for CD32A. Cells were fractionated prior to incubation with CD32A antibody and subsequent samples isolated using protein agarose beads.
ORGANISM(S): Homo sapiens (Human) 
2023-09-05 | PXD042514 | Pride
K562 Fcgr2a Cd32a 
ProteomicsSite-specific analysis of CD16a and CD32a N-glycosylation from monocytes display donor variability which modulate affinity to IgG1 Fc
Glycopeptide mass spectra of CD16a and CD32a from isolated monocytes display donor and site variability. CD16a N-glycosylation composition affects the affinity of IgG1 Fc. Peptide coverage of CD16a was ~85% while CD32a was ~61%.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2019-06-26 | MSV000084012 | MassIVE
UnknownFcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.
Not available
S-EPMC7537387 | biostudies-literature
UnknownMass Cytometry Analysis Reveals the Landscape and Dynamics of CD32a+ CD4+ T Cells From Early HIV Infection to Effective cART.
Not available
S-EPMC5995043 | biostudies-literature
UnknownThe Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.
Not available
S-EPMC7213910 | biostudies-literature
UnknownDevelopment of CRISPR/Cas9-mediated CD16b<sup>-/-</sup> and CD32a<sup>-/-</sup> promyelocytic cell lines to study FcγR signaling in human neutrophils.
Not available
S-EPMC12528219 | biostudies-literature
UnknownA Comparative Analysis of CD32A and CD16A Polymorphisms in Relation to Autoimmune Responses in Pemphigus Diseases and Subepithelial Autoimmune Blistering Disorders.
Not available
S-EPMC7231204 | biostudies-literature
TranscriptomicsC-reactive protein promotes bone destruction in human myeloma by stimulating myeloma cell production of osteolytic cytokines via the CD32A-p38MAPK-twist axis
Bone destruction is a hallmark of human myeloma and affects more than 80% of patients. Although it is well established that myeloma cells mediate bone destruction by activating osteoclasts, the mechanism how myeloma cells are regulated to do so is unknown. Here we show that C-reactive protein (CRP),...
ORGANISM(S): Homo sapiens 
2017-09-12 | GSE103697 | GEO
UnknownOral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?
Not available
S-EPMC6963242 | biostudies-literature
UnknownIn vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Not available
S-EPMC8711771 | biostudies-literature
Sort   by:  
 Page size